Life Sciences MVP: Sullivan's Krishna Veeraraghavan
By Jessica Corso ( December 2, 2015, 7:52 PM EST) -- Krishna Veeraraghavan's experience at the helm of multiple record-breaking deals benefited Teva Pharmaceuticals earlier this year when the pharmaceutical giant abruptly switched from a $40 billion bid for Mylan to a successful $40.5 billion offer for Allergan's generics business, earning the Sullivan & Cromwell LLP partner a solid spot on Law360's 2015 list of MVPs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.